Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1195)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 22, 2024 1:16pm
RE:RE:Ok
Haha Bucky has given us the all clear folks.... forge ahead. Oh and it's nice that one of our biggest, albeit dumbest, detractors thinks $5 billion is reality. What a day, what a day
...more
(143)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 22, 2024 1:08pm
RE:Ok
Good to see the pumpers finally coming back to reality on buyout price. Was not long ago they were 10 to 25B. Now can we continue the discussion on capital gains!!!
New PEA Indicates an Ultra Low-Cost Uranium Project with Huge Exploration Upside
posted Apr 26, 2024 9:00am by
Blue Sky Uranium Corp
-
|
This PEA reaffirms that the deposit is a leading low-cost uranium-vanadium project. We believe that this resurgent uranium market has a strong long-term outlook and we are therefore preparing to complete a prefeasibility study as soon as possible ...read more
(848)
•••
canadafan
X
View Profile
View Bullboard History
Post by
canadafan
on Apr 22, 2024 12:34pm
News before end of this quarter?
I agree 100% with the many comparables that notable has enlighten this board with. The $1-$5 billion range of acquisitions is happening in the biotech world. The pharma companies are doing well with
...more
(511)
•••
Lesalpes29
X
View Profile
View Bullboard History
Post by
Lesalpes29
on Apr 22, 2024 11:24am
Ok
Added some. Let Matt get us a surprise before this quarter end.
(5327)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 22, 2024 11:10am
RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
The number of patients at later time points in the Alpine Immune Science povetacicept phase 1b clinical trial, now reported as a Phase 3 ready clinical candidate, is only six patients in the 80mg dose
...more
(5327)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 22, 2024 10:55am
RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
As posted on April 11, 2024 - Vertex Pharmaceuticals is acquiring Phase 1b Alpine Immune Sciences for $4.9 billion, gaining access to povetacicept, a potential treatment for IgA nephropathy and up to
...more
(5327)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 22, 2024 9:41am
RE:RE:EU Legislative proposals aims to expedite new medicines
As concluded, this newly affected collaborated effort by international governments to reduce international "red-tape" and facilitate collective international regulatory decision-making for
...more
(511)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Apr 22, 2024 9:09am
RE:RE:RE:Peladumdum...
OK I stop. Just add one more clown on my ignore list. Now I can only read CFan Johnny Casey loll!
(511)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Apr 22, 2024 9:01am
RE:RE:Peladumdum...
11 peladumdum pelastupidos! And so on...
(109)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Apr 22, 2024 9:01am
RE:RE:Peladumdum...
Shouldn't it be nap time at your daycare. Kids, stop fighting! Mommy and Daddy aren't going to be happy with your behaviour. SH admin. Get rid of this BS!!
(316)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Apr 22, 2024 8:51am
RE:Peladumdum...
Peladumdum?!....lol.....what are you Les...12 years old?
(511)
•••
Lesalpes29
X
View Profile
View Bullboard History
Post by
Lesalpes29
on Apr 22, 2024 8:38am
Peladumdum...
Working hard with your small brain...
(1195)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 22, 2024 8:35am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Canada's 2024 Federal Budget increases capital gains tax
Enough said!!!
(38)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Apr 22, 2024 8:14am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Canada's 2024 Federal Budget increases capital gains tax
Enough said...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update